Ross Shikowitz is a Partner at BFA, and focuses his practice on investigating, analyzing and prosecuting complex securities matters on behalf of institutional investors. For over a decade, Ross has been advising many of the world’s largest and most sophisticated institutional investors concerning their rights and potential legal claims arising out of securities-related matters. He is a leader of the firm’s client monitoring and case evaluation group, in which he, together with a team of attorneys and financial analysts, develops and recommends legal strategies to the firm’s clients.
Ross was one of the lead litigators for the securities class action against Granite Construction Incorporated, which achieved a $129 million resolution on behalf of the class. Ross also plays a key role representing investors in the securities class actions concerning Talis Biomedical Corp. ($32.5 million resolution), Gatos Silver, Inc. ($21 million resolution), TaskUs, Inc., ($17.5 million resolution, pending court approval), Bioventus Inc. ($15.25 million resolution), The Toronto-Dominion Bank, CVS Health Corporation, Five9, Inc., and UiPath, Inc.
Ross has consistently been named as a “Rising Star” and a member of “Super Lawyers” in the area of securities litigation by Thomson Reuters Super Lawyers. He was also recognized by Legal 500 for his work representing investors.
Ross serves as a Vice President of the Institute for Law and Economic Policy, a public policy research and educational foundation focused on preserving, studying, and enhancing investor and consumer access to the civil justice system. He previously served as a member of Law 360 Securities Editorial Advisory Board, providing the organization with expert insight into relevant trends in securities litigation. Ross has authored several articles focused on investor protection that have been published by the Harvard Law School Forum on Corporate Governance, National Association of Public Pension Attorneys and the National Conference on Public Employee Retirement Systems, among others.
Prior to joining the firm, Ross successfully represented numerous institutions that were misled when investing in residential mortgage-backed securities, and participated in the resolution of securities class actions concerning a European car manufacturer as well as a U.S. technology company.
| Case | Type | Status |
|---|---|---|
| Apple Inc. | U.S. Securities Litigation | New |
| Bellring Brands, Inc. | U.S. Securities Litigation | New |
| Bilinsky v. Gatos Silver, Inc. et al. | U.S. Securities Litigation | Settled |
| Centene Corporation | U.S. Securities Litigation | New |
| Fortrea Holdings Inc. | U.S. Securities Litigation | New |
| Hims & Hers Health, Inc. | U.S. Securities Litigation | New |
| In re ICON plc Securities Litigation | U.S. Securities Litigation | Pending |
| In re Talis Biomedical Securities Litigation | U.S. Securities Litigation | Settled |
| In re UiPath Securities Litigation | U.S. Securities Litigation | Pending |
| Lozada v. TaskUs, Inc. et al. | U.S. Securities Litigation | Pending |
| Lucid Alternative Fund, LP v. Five9, Inc. et al. | U.S. Securities Litigation | Pending |
| Moline v. BioVentrix, Inc. | Corporate Governance | Pending |
| Neogen Corporation | U.S. Securities Litigation | New |
| Nixon v. CVS Health Corporation et al. | U.S. Securities Litigation | Pending |
| Olo Inc. | Corporate Governance | New |
| Reddit, Inc. | U.S. Securities Litigation | New |
| Replimune Group | U.S. Securities Litigation | New |
| RxSight, Inc. | U.S. Securities Litigation | New |
| Sarepta Therapeutics, Inc. | U.S. Securities Litigation | New |
| The Police Retirement System of St. Louis v. Granite Construction Incorporated et al. | U.S. Securities Litigation | Settled |
| Tiessen v. The Toronto-Dominion Bank et al. | U.S. Securities Litigation | Pending |